Episode Details
Back to Episodes
Episode 527: ESMO 2026 - DASL-HiCaP Adding Darolutamide to ADT and XRT in High-risk Localized Prostate Cancer
Published 1 day, 19 hours ago
Description
Chris Sweeney discusses this ANZUP trial which adds more phase 3 data to the high risk prostate cancer space.